# IMX-150 Cream for Diabetic Neuropathy

> **NCT00641953** · PHASE2 · COMPLETED · sponsor: **Procris Pharmaceuticals** · enrollment: 155 (actual)

## Conditions studied

- Diabetic Peripheral Neuropathy

## Interventions

- **DRUG:** IMX-150
- **DRUG:** IMX-150
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00641953
- **Lead sponsor:** Procris Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2008-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00641953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00641953, "IMX-150 Cream for Diabetic Neuropathy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00641953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*